Abarbanel Mental Health Centre, Bat Yam, Israel.
World J Biol Psychiatry. 2012 Jan;13(1):2-13. doi: 10.3109/15622975.2011.559271. Epub 2011 May 9.
To investigate the prevalence of obsessive-compulsive symptoms in schizophrenia, the clinical features of the sub-group of patients with schizophrenia and obsessive-compulsive symptoms and treatment options for these patients.
A literature review of studies investigating the prevalence, clinical features and treatment of patients with schizophrenia and obsessive-compulsive symptoms.
The prevalence of obsessive-compulsive symptoms in schizophrenic patients, while generally found to be higher than in the general population, varies widely between different studies. Differences in symptom severity between schizophrenic patients with obsessive-compulsive symptoms and those without have been found, however findings so far have been inconsistent. A number of case reports have implicated atypical antipsychotic medication in the emergence of obsessive-compulsive symptoms. There is evidence to support a combined treatment with an antipsychotic agent and an anti-obsessional agent.
Studies investigating the prevalence of obsessive-compulsive symptoms in schizophrenia and their effect on the clinical symptoms have yielded inconsistent results and further studies using larger samples of patients and looking at different subgroups of schizophrenic patients are required. Treatment options need further research to investigate whether the results of relatively small studies can be replicated.
探讨精神分裂症患者中强迫症症状的患病率,伴有强迫症症状的精神分裂症患者亚组的临床特征及这些患者的治疗选择。
对研究精神分裂症伴强迫症患者的患病率、临床特征和治疗的文献进行综述。
精神分裂症患者中强迫症症状的患病率虽普遍高于一般人群,但在不同研究中的差异很大。伴有强迫症症状的精神分裂症患者与不伴强迫症症状的患者在症状严重程度上存在差异,但迄今的研究结果并不一致。一些病例报告提示非典型抗精神病药物与强迫症症状的出现有关。有证据支持联合使用抗精神病药物和抗强迫药物的治疗。
研究精神分裂症中强迫症症状的患病率及其对临床症状的影响得出了不一致的结果,需要使用更大的患者样本和研究不同亚组的精神分裂症患者进行进一步的研究。治疗选择需要进一步研究,以验证相对较小的研究结果是否可以复制。